TickerFactsScreenerDevelopers

NovoCure Ltd (NVCR) — Operating Income

Annual figures by fiscal year, from SEC filings.

2013: -$64.46M2014: -$80.16M2015: -$104.00M2016: -$115.32M2017: -$39.33M2018: -$33.67M2019: -$914.0K2020: $30.40M2021: -$44.33M2022: -$89.52M2023: -$232.87M2024: -$170.50M2025: -$153.80M-$153.80M
2013Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$153.80M+9.8%
2024-$170.50M+26.8%
2023-$232.87M-160.1%
2022-$89.52M-101.9%
2021-$44.33M-245.8%
2020$30.40M+3426.1%
2019-$914.0K+97.3%
2018-$33.67M+14.4%
2017-$39.33M+65.9%
2016-$115.32M-10.9%
2015-$104.00M-29.7%
2014-$80.16M-24.4%
2013-$64.46M—